Skip to content
AwardedDNKGoodsFramework agreementDKK 2,270,000

Amgros 2026 1.811.a

Published
Published 28 January 2026
Deadline
Closed 12 March 2026

Overview

Amgros I/S, a pharmaceutical procurement cooperative representing Denmark's five regions, awarded a framework agreement to Gilead Sciences Denmark ApS on 11 May 2026 for the supply of pharmaceutical products. The agreement, valued at 210,000 DKK, is non-exclusive and enables supply to regional hospital pharmacies with potential resale to the Faroe Islands and Greenland, with no mandatory purchase obligations.

Key details

Country
DNK
Status
Awarded
Category
Goods
Estimated value
DKK 2,270,000
Procedure
Open
Contract type
Framework agreement
Published
28 January 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
DKK 210,000
Award date
11 May 2026
Contract period
1 October 2026 → 30 November 2029
Winner
  • Gilead Sciences Denmark ApS

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    11 May 2026

  2. Contract Notice

    28 January 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Amgros 2026 1.811.a — won by Gilead Sciences Denmark ApS — Skim